Treatment of Inpatient Asymptomatic Hypertension: Not a Call to Act but to Think

James Anstey¹, Brian P Lucas^{2

3

4}

Affiliations

¹ Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California.
² Medicine Service, White River Junction VA Medical Center, White River Junction, Vermont.
³ Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire.
⁴ The Dartmouth Institute for Health Policy & Clinical Practice, Hanover, New Hampshire.

Editorial

James Anstey et al. J Hosp Med. 2019 Mar.

. 2019 Mar;14(3):190-191.

doi: 10.12788/jhm.3160.

James Anstey¹, Brian P Lucas^{2

3

4}

¹ Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California.
² Medicine Service, White River Junction VA Medical Center, White River Junction, Vermont.
³ Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire.
⁴ The Dartmouth Institute for Health Policy & Clinical Practice, Hanover, New Hampshire.

No abstract available

Comment on

Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.
Jacobs ZG, Najafi N, Fang MC, Prasad PA, Abe-Jones Y, Auerbach AD, Patel S. Jacobs ZG, et al. J Hosp Med. 2019 Mar;14(3):144-150. doi: 10.12788/jhm.3087. J Hosp Med. 2019. PMID: 30811319
Assess Before Rx: Reducing the Overtreatment of Asymptomatic Blood Pressure Elevation in the Inpatient Setting.
Pasik SD, Chiu S, Yang J, Sinfield C, Zubizarreta N, Ramkeesoon R, Cho HJ, Krouss M. Pasik SD, et al. J Hosp Med. 2019 Mar;14(3):151-156. doi: 10.12788/jhm.3190. J Hosp Med. 2019. PMID: 30811320